BIT
ATRA icon

BlackRock Institutional Trust’s Atara Biotherapeutics ATRA Stock Holding History

BlackRock Institutional Trust’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7.19M Buy
20,255
+195
+1% +$82.6K ﹤0.01% 2590
2016
Q3 		$10.7M Buy
20,060
+475
+2% +$258K ﹤0.01% 2298
2016
Q2 		$11M Buy
19,585
+2,895
+17% +$1.39M ﹤0.01% 2235
2016
Q1 		$7.94M Buy
16,690
+1,074
+7% +$483K ﹤0.01% 2409
2015
Q4 		$10.3M Buy
15,616
+321
+2% +$243K ﹤0.01% 2301
2015
Q3 		$12M Buy
15,295
+7,948
+108% +$9.69M ﹤0.01% 2163
2015
Q2 		$9.69M Buy
7,347
+4,433
+152% +$5.09M ﹤0.01% 2425
2015
Q1 		$3.03M Buy
2,914
+1,142
+64% +$755K ﹤0.01% 2940
2014
Q4 		$1.19M Buy
+1,772
New +$1.08M ﹤0.01% 3299

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return